Fly News Breaks for July 25, 2019
Jul 25, 2019 | 07:36 EDT
Oppenheimer analyst Steven Lichtman raised his price target for Integra LifeSciences to $70 from $65 following quarterly results. The analyst reiterates an Outperform rating on the shares.
News For IART From the Last 2 Days
There are no results for your query IART